15 Stocks That Took a Nosedive in January
Historically, the S&P 500's performance in January sets the pace for the rest of the year.
Viking Therapeutics Inc. (VKTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,485,079 | $59,759,579 | +1% | 0.01% |
| 2. | Braidwell LP Alex Karnal | 1,479,666 | $59,541,760 | +28% | 1.76% |
| 3. | 1,286,500 | $51,768,760 | -1% | 0% | |
| 4. | Perceptive Advisors Joseph Edelman | 995,894 | $40,074,775 | -42% | 1.1% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 860,449 | $34,624,468 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.47 | 45,000 | Director | 111,250 | 2022-05-02 | Filing | |
| $5.69 | 20,000 | Director | 66,250 | 2021-06-10 | Filing | |
| $9.82 | 9,500 | Director | 9,500 | 2018-05-31 | Filing | |
| $5.16 | 30,000 | Director | 30,000 | 2018-05-29 | Filing | |
| $5.21 | 8,000 | Director | 8,000 | 2018-05-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.32 | 19,000 | 2,366,570 | 2025-01-06 | Filing | ||
| $42.68 | 175,490 | 2,385,570 | 2025-01-06 | Filing | ||
| $43.32 | 5,100 | 374,134 | 2025-01-06 | Filing | ||
| $42.69 | 49,115 | 379,234 | 2025-01-06 | Filing | ||
| $43.32 | 4,700 | 165,259 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,715,438 | $672,629,202 | 0.04% | |
| 2. | 10,172,441 | $409,339,025 | 0% | |
| 3. | 5,872,978 | $236,328,636 | 0% | |
| 4. | 4,925,490 | $198,201,718 | 0% | |
| 5. | 2,593,615 | $104,367,109 | 0% |
News See All
Jim Cramer's Thoughts on These 7 Stocks
Jim Cramer, the host of Mad Money, recently revisited one of his core investment principles: "Nobody ever made a dime panicking." He emphasized that, no matter how many times he has shared this advice...
Jim Cramer’s Lightning Rounds: 9 Stocks in Focus
Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock market's expectations for...
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
10 Stocks That Will Make You Rich In 2025
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
11 Reddit Stocks with Biggest Upside Potential
Paul Hickey, Bespoke co-founder, together with Dana D'Auria, Envestnet co-chief Investment Officer, joined CNBC's 'Closing Bell: Overtime' on November 12 to discuss the market's reaction to the election...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2024 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Third Quarter 2024 Financial Results Conference Call. At this time, all parties are in a listen-only mode.
Billionaire Hedge Funds
